Journals / KONURALP TIP DERGİSİ / 2020 / Cilt: 12 - Sayı: 1

A New Marker in Acute Ischemic Stroke Patients: Monocyte / HDL Ratio

AKUT İSKEMİK İNME HASTALARINDA YENİ BİR MARKIR: MONOSİT/HDL ORANI

Pages
118–123
Publication Date
2020-03-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The MHR correlated with both the clinical condition and infarct area in acute ischemic stroke patients, which underscores the value of MHR as a new marker.Conclusion: This cross-sectional study of 91 acute ischemic stroke patients indicates that inflammation markers and MHR are correlated with clinical status and even radiological parameters.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Stroke is a major cause of global morbidity and mortality.
📊
Key Findings & Data:MHR can be used a prognostic marker in stroke patients base on this theory.Method: Our study registered 91 acute ischemic stroke patients (47 females and 44 males) and 50 healthy controls.Results: MHR was elevated in the patient group and correlated with high-sensitivity C-reactive protein (hsCRP).
💡
Conclusion & Impact:The MHR correlated with both the clinical condition and infarct area in acute ischemic stroke patients, which underscores the value of MHR as a new marker.Conclusion: This cross-sectional study of 91 acute ischemic stroke patients indicates that inflammation markers and MHR are correlated with clinical status and even radiological parameters.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:akut iskemik inme · monosit/HDL oranı · inflamasyon

Abstract

Objective: Stroke is a major cause of global morbidity and mortality. Ischemic stroke is usually marked by cell death associated with inflammation and oxidative stress, and the role of inflammation in neurological diseases has become increasingly obvious. In our study, we studied the monocyte / HDL ratio (MHR) which can support the theory of inflammation in stroke and can be used in clinical practice. MHR can be used a prognostic marker in stroke patients base on this theory.Method: Our study registered 91 acute ischemic stroke patients (47 females and 44 males) and 50 healthy controls.Results: MHR was elevated in the patient group and correlated with high-sensitivity C-reactive protein (hsCRP). MHR was higher in patients with high a National Institutes of Health Stroke Scale (NIHSS) than those with a low NIHSS (p=0.050) as well as in patients with a larger infarct area and in than those with a smaller area (p=0.050). The MHR correlated with both the clinical condition and infarct area in acute ischemic stroke patients, which underscores the value of MHR as a new marker.Conclusion: This cross-sectional study of 91 acute ischemic stroke patients indicates that inflammation markers and MHR are correlated with clinical status and even radiological parameters.

Özet

Amaç:İnme, dünyada major bir morbidite ve mortalite sebebidir. İskemik inmede genellikle inflamasyon ve oksidatif strese bağlı hücre ölümü görülür. Nörolojik hastalıklarda inflamasyonun rolü giderek daha da belirginleşmektedir. Çalışmamızda inmede inflamasyon teorisini destekleyebilen ve klinik uygulamada kullanılabilecek monosit / HDL oranını (MHO) inceledik. Gereç ve Yöntem:Çalışmamızda 91 akut iskemik inme hastası (47 kadın ve 44 erkek) ve 50 sağlıklı kontrol kaydedildi.Bulgular:Hasta grubunda MHO yüksek idi ve yüksek duyarlılıkta C-reaktif protein (hsCRP) ile korele idi. MHO, Ulusal Sağlık Enstitüleri İnme Ölçeği (NIHSS) skoru yüksek olan hastalarda, düşük NIHSS'li (p = 0.050) olanların yanı sıra, ve de daha büyük bir infarkt alanı olanlarda daha küçük infarkt alanına sahip olanlara (p = 0.050) göre daha yüksekti. MHO, yeni bir belirteç olarak, akut iskemik inme hastalarında, hem klinik durum hem de infarkt alanı ile koreledir.Sonuç:91 akut iskemik inme hastasının, bu cross-sectional çalışması, inflamasyon belirteçlerinin ve MHO'nin; klinik durum ve hatta radyolojik parametrelerle korele olduğunu göstermektedir.

🔖

Cite This Article

ALAGÖZ, A. N., ACAR, B. A., GÜNGEN, B., ARAS, Y., ACAR, T. (2020). A New Marker in Acute Ischemic Stroke Patients: Monocyte / HDL Ratio. KONURALP TIP DERGİSİ, Cilt: 12 - Sayı: 1, 118–123. https://ajindex.com/articles/686709

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Sengupta D, Bardhan J, Baran A, Mahapatra S, Banerjee J, Rout JK. Correlation between lipid profile and carotid intima media thickness in cerebral ischemia. Indian J PhysiolPharmacol. 2014 Oct-Dec
  2. 58(4):354-64. 2.Chehaibi K, Trabelsi I, Mahdouani K, Slimane MN. Correlation of oxidative stress parameters and inflammatory markers in ischemic stroke patients. J Stroke Cerebrovasc Dis. 2016 Nov
  3. 25(11):2585-2593. 3.Lénárt N, Brough D, Dénes Á. Inflammasomes link vascular disease with neuroinflammation and brain disorders. J Cereb Blood Flow Metab. 2016 Oct
  4. 36(10):1668-1685. 4.Taleb S. Inflammation in atherosclerosis. Arch Cardiovasc Dis. 2016 Aug 29. pii: S1875-2136(16)30112-7. 5.Canpolat U, Çetin EH, Cetin S, et al. Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation. ClinApplThrombHemost. 2016 Jul
  5. 22(5):476-82. 6.Ancuta P, Wang J, Gabuzda D. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol. 2006
  6. 80(5):1156-1164. 7.Kanbay M, Solak Y, Unal HU, et al. Monocyte count/HDL-C ratio and cardiovascular events in patients with chronic kidney disease. IntUrolNephrol. 2014
  7. 46(8): 1619-1625. 8.Bolayır A,Gokce SF, Cigdem B, et al. Monocyte/high density lipoprotein ratio predicts the mortality in ischemic stroke patients. Neurol Neurochir Pol. 2018 Mar
  8. 52(2):150-155. doi: 10.1016/j.pjnns.2017.08.011. Epub 2017 Aug 24. 9. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of ORG 10172 in Acute Stroke Treatment. Stroke. 1993
  9. 35–41. 10. Brott T, Adams HP, Jr., Olinger CP et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989
  10. 20(7):864-70. 11.Minić GA. Leucocyte count indicates carotid plaque instability in stroke patients. Vojnosanit Pregl. 2016 Jun
  11. 73(6):515-25. 12.Matsuo R, Ago T, Hata J, et al. Plasma C-reactive protein and clinical outcomes after acute ischemic stroke: A prospective observational study. PLoS One. 2016 Jun 3
  12. 11(6):e0156790. 13.Leuschner F, Rauch PJ, Ueno T et al. Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med. 2012 Jan 16
  13. 209(1):123-37. 14.Ghattas A, Griffiths HR, Devitt A, Lip GY, Shantsila E. Monocytes in coronary artery disease and atherosclerosis: Where are we